Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells
(Q44262979)
scientific article
scientific article
Language:
Current Data About
Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
BR521-6
|
||||||||||||||||||||||||
| (P433) |
12
|
||||||||||||||||||||||||
| (P478) |
8
|
||||||||||||||||||||||||
| (P577) |
Sunday, December 1, 2002
|
||||||||||||||||||||||||
| (P921) |
(Q61643320)
(Q7240673)
|
||||||||||||||||||||||||
| (P1433) |
(Q15756323)
|
||||||||||||||||||||||||
| (P1476) |
"Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Anne Camirand
Yuhong Lu
Michael Pollak
|